revealed that SIT impeded the viability of human breast cancer cells (MCF-7 and MDA-MB-231) through regulation of the PI3K/Akt/mTOR pathway, possibly the primary mechanism of its anti-tumor activity. The gene discussed is AKT1; the disease is breast cancer.